photos

COVID-19 Vaccine

66-yr old Lakhi Narayan Das (L) who wants to volunteer for COVID-19 vaccine candidate trial, walks his son Rakesh Das to get information from ICMR-NICED, as the phase-III regulatory trial of COVAXIN is underway, in Kolkata.

PTI Photo

Russian President Vladimir Putin attends a meeting via video conference at the Novo-Ogaryovo residence outside Moscow, Russia. Russian President Vladimir Putin announced start of large-scale vaccination of medics and teachers against COVID next week. Speaking during an online meeting dedicated to inauguration of new hospitals for coronavirus patients built by Russian Defense Ministry, Putin said Russia has enough capacity to start "large-scale" vaccination of teachers and doctors.

AP/PTI

Britain's Prime Minister Boris Johnson holds a vial of the Oxford/AstraZeneca vaccine Covid-19 candidate vaccine, known as AZD1222, at Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales.

AP/PTI Photo

Prime Minister Narendra Modi at Serum Institute of India, during his 3 city visit to review COVID-19 vaccine development work, in Pune.

PIB/PTI Photo

Prime Minister Narendra Modi chairs a meeting at Serum Institute of India, during his 3 city visit to review COVID-19 vaccine development work, in Pune.

PIB/PTI Photo

View of Serum Institute of India, during Prime Minister Narendra Modi's 3 city visit to review COVID-19 vaccine development work, in Pune.

PTI Photo

Prime Minister Narendra Modi visis the Zydus Biotech Park to review the development of COVID-19 vaccine, in Ahmedabad.

PTI Photo

Prime Minister Narendra Modi being briefed during a visit to the Bharat Biotech facility to review the development of indigenous COVID-19 vaccine candidate Covaxin, on the outskirts of Hyderabad

PTI Photo

Prime Minister Narendra Modi at Bharat Biotech facility during his 3 city visit to review COVID-19 vaccine development work, in Hyderabad.

PTI Photo

Prime Minister Narendra Modi at Bharat Biotech facility during his 3 city visit to review COVID-19 vaccine development work, in Hyderabad.

PTI Photo

Prime Minister Narendra Modi during a visit to the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila.

PTI Photo

Security deployed at Zydus Biotech park during Prime Minister Narendra Modi's visit to review the development of COVID-19 vaccine ZyCOV-D, at Changodar in Ahmedabad.

PTI Photo

45-yr old Umesh Thakur, a volunteer for the 2nd phase trial of the India-made COVID-19 vaccine Covaxin, at his residence in Ghaziabad.

PTI Photo/Arun Sharma

24-yr old Raj Kumar, a volunteer for the 2nd phase trial of the India-made COVID-19 vaccine Covaxin, at Taj Mahal in Agra.

PTI Photo

45-yr old Umesh Thakur (C), a volunteer for the 2nd phase trial of the Covaxin, comes out after a routine check-up at AIIMS in New Delhi. Umesh, a State Civil Services aspirant, is excited to be part of this trial.

PTI Photo/Arun Sharma

24-yr old Raj Kumar, a volunteer for the 2nd phase trial of the India-made COVID-19 vaccine Covaxin, in Agra

PTI Photo

In this undated photo issued by the University of Oxford, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals.

Photo by AP/PTI

Haryana Health Minister Anil Vij volunteers in the trials for potential coronavirus vaccine Covaxin, at Civil Hospital in Ambala district.

PTI Photo

Haryana Health Minister Anil Vij volunteers in the trials for potential coronavirus vaccine Covaxin, at Civil Hospital in Ambala district.

PTI Photo

A shot of Russia's experimental Sputnik V coronavirus vaccine is shown before its use in Moscow, Russia. Russian health authorities have launched advanced trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study.

Photo by AP/PTI

A Russian medical worker adminsters a shot of Russia's experimental Sputnik V coronavirus vaccine in Moscow, Russia. Russian health authorities have launched advanced trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study.

Photo by AP/PTI

A Russian medical worker prepares a shot of Russia's experimental Sputnik V coronavirus vaccine for its use in Moscow, Russia. Russian health authorities have launched advanced trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study.

Photo by AP/PTI

In this handout photo provided by Russian Direct Investment Fund, an employee works with a coronavirus vaccine at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia on Tuesday, Aug. 11 became the first country to approve a coronavirus vaccine for use in tens of thousands of its citizens despite international skepticism about injections that have not completed clinical trials and were studied in only dozens of people for less than two months.

AP/PTI

In this handout photo provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia became the first country to approve a coronavirus vaccine for use in tens of thousands of its citizens despite international skepticism about injections that have not completed clinical trials and were studied in only dozens of people for less than two months.

Photo by AP/PTI

Prime Minister Narendra Modi chairs a high-level meeting to review the planning and preparations for vaccination against COVID-19, through video conferencing, in New Delhi.

PIB/PTI Photo

A lab technician extracts a portion of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand. Researchers in Thailand claim to have promising results with the vaccination on mice, and have begun testing on monkeys.

Photo by AP/PTI

Prime Minister Narendra Modi chairs a meeting of the task force on Coronavirus vaccine development, in New Delhi. PM also took a detailed review of the current status of India’s steady efforts in vaccine development, drug discovery, diagnosis and testing.

PTI Photo